Cecal Perforation in the Setting of Campylobacter jejuni Infection by Jain, Seema et al.
Faculty Scholarship 
2019 





Follow this and additional works at: https://researchrepository.wvu.edu/faculty_publications 







































ACG CASE REPORTS JOURNAL
CASE REPORT | COLON
Cecal Perforation in the Setting of Campylobacter
jejuni Infection
Seema Jain, MD1, Weston Bettner, MD2, Dane C. Olevian, MD3, and Dhiraj Yadav, MD, MPH2
1Department of Internal Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA
2Department of Gastroenterology, Hepatology and Nutrition, University of Pittsburgh Medical Center, Pittsburgh, PA
33Department of Pathology, Anatomy, and Laboratory Medicine, West Virginia University, Morgantown, WV
ABSTRACT
Campylobacter infection is the leading cause of bacterial gastroenteritis worldwide, yet life-threatening complications are extremely
rare. We present a 32-year-old previously healthy man who presented with dysentery from Campylobacter jejuni, which was
complicated by cecal perforation and secondary bacterial peritonitis.
INTRODUCTION
Campylobacter is the leading cause of bacterial gastroenteritis worldwide, withCampylobacter jejuni being themost common species
to cause illness. Typically, C. jejuni causes acute self-limited gastroenteritis. However, 10%–20% of culture-confirmed cases in the
United States require hospitalization.1 Acute enteric complications are uncommon and include mesenteric adenitis, pseudomem-
branous colitis, massive gastrointestinal bleeding, ischemic bowel disease, and bowel perforation.1,2 Colonic perforation is ex-
ceedingly rare; only a handful of reported cases exist, primarily in the context of toxicmegacolon.3,4We present a case of enterocolitis
secondary to C. jejuni complicated by cecal perforation.
CASE REPORT
A32-year-old previously healthyman presentedwith 4 days of fevers, bilateral lower quadrant abdominal pain, and bloody diarrhea after
returning from a 9-day trip to Japan. Stools were initially watery but progressed to a bloody, currant-jelly consistency.Hewas febrile up to
39.5°C before presentation. He presented to the emergency department 1 day after returning from his trip, where he was febrile to 38.2°C
and tachycardic to 108beats perminute.Abasicmetabolic panel and complete bloodcountwere remarkable formildhyponatremiaof 132
mmol/L andmildhypokalemiaof 3.3mmol/L; no leukocytosiswas evident. Stool sampleswereobtained, andhewasdischargedona3-day
course of azithromycin for the treatment of dysentery. Within 12 hours, however, he re-presented with severe right lower quadrant
abdominal pain. Abdominal and pelvic computed tomography (CT) scan demonstrated acute enterocolitis consisting of moderately
distended, thickened,fluid-filled loopsof thedistal ileumandcolon,mostprominent in the righthemicolonandcecum(Figure1).Reactive
mesenteric lymph nodes up to 1.5 cm in the right lower quadrant and diffuse mesenteric edema were also demonstrated.
The patient was given intravenous fluids and discharged. Despite 2 days of adherence to azithromycin therapy, he had persistent
symptoms and so presented to the infectious disease clinic. Stool nucleic acid amplification testing had by then returned positive for
C. jejuni with negative results for other bacterial pathogens. He was admitted for initiation of intravenous meropenem, given
a concern for macrolide resistance.
On admission, he remained tachycardic and developed a leukocytosis to 12.63 109 cells/L with neutrophil predominance. On day 2
of admission, he developed a new singultus with an abdominal examination demonstrating rebound and guarding. His laboratory
results were remarkable for a newbandemia of 22%and a fall in his albumin from3.8 to 2.8 g/dL. An abdominal x-ray revealed free air
underlying the diaphragm (Figure 2).
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The patient underwent an emergent exploratory laparotomy,
which revealed cecal perforation complicated by gross fecal
contamination of the abdomen. Peritoneal cultures were
obtained, and an ileocolic resection with a side-to-side ileoco-
lonic anastomosis was performed. Pathology demonstrated ac-
tive enterocolitis with ulceration, patchy mild crypt distortion,
transmural colonic perforation, and acute serositis (Figure 3).
There was no evidence of chronic mucosal injuries such as
granulomas, transmural chronic inflammation, or mural scar-
ring, arguing against an underlying diagnosis of inflammatory
bowel disease. Intraoperative cultures grew pan-sensitive En-
terococcus faecalis,whereas blood cultures remained negative.He
was treated with 8 days of meropenem overlapped with 3 days
of gentamicin for empiric treatment of C. jejuni. Antibiotic
therapy was extended with an additional 4 days of piperacillin-
tazobactam to complete treatment of E. faecalis.
Postoperatively, hishemoglobindropped from12.2 to7.5g/dLover
the course of 4 days with no overt gastrointestinal bleeding. A CT
scandemonstrated a largehematoma in the right lowerquadrant of
the retroperitoneum without active contrast extravasation on an-
giogram. The patient then underwent a repeat exploratory lapa-
rotomy that revealed a large clot in the pelvis near the anastomosis,
whichwas evacuated; no active source of bleedingwas seen, andhis
hemoglobin stabilized thereafter. He subsequently developed
a postoperative ileus and briefly required total parenteral nutrition.
He was discharged on hospital day 16 with negative pressure
wound therapy. He was evaluated in the clinic 2 weeks after dis-
charge with significant improvement in his symptoms.
DISCUSSION
Campylobacter jejuni infection typically causes acute self-
limited gastroenteritis or colitis with symptoms lasting 1 day to
1 week. The most common symptoms are crampy abdominal
pain, malaise, fever, and diarrhea, with stools that can range
from loose to watery to bloody.2 The cornerstone of treatment,
as for any diarrheal illness, is fluid and electrolyte replacement.5
In a meta-analysis of 11 small randomized trials, antimicrobial
therapy, when started early in the disease course, reduced du-
ration of symptoms by 1.3 days.6 Antimicrobial therapy is
typically reserved for patients with severe symptoms such as
high fever, massive or bloody diarrhea, or symptoms persisting
for more than 1 week. Owing to increased rates of fluo-
roquinolone resistance, macrolides are considered first-line
therapy when antimicrobials are warranted.5
Identifying and treating patients at risk for enteric complica-
tions ofC. jejuni infection is challenging as complications are so
rare. Only a handful of cases of perforation from C. jejuni in-
fection have been reported. In previous cases of perforation,
patients had suddenworsening of their abdominal examination
along with concurrent fevers and increasing leukocytosis before
the development of toxic megacolon.3,4,7 Similarly, our patient
had an ongoing systemic inflammatory response despite ade-
quate fluid resuscitation and antimicrobial therapy as his ab-
dominal examination progressed to an acute abdomen.
Persistent systemic inflammatory response criteria in concor-
dance with other inflammatory laboratory markers despite
adequate initial therapymay, therefore, be helpful in identifying
patients at risk for toxicity who warrant serial examinations or
repeat imaging. Our patient developed a new leukocytosis on
admission followed by a bandemia and hypoalbuminemia ap-
proximately 12 hours before his surgical resection. C-reactive
protein was not checked for our patient but may have been an
additional helpful tool for risk stratification, as markedly ele-
vated C-reactive protein was noted in 2 cases of bowel perfo-
ration secondary to C. jejuni.7,8
Figure 1. Abdominal and pelvic computed tomography showing
distended and thickened fluid-filled loops of distal ileum and colon.
Figure 2. Abdominal x-ray showing large volume pneumo-
peritoneum with diffuse distended and dilated loops of the small
bowel and numerous air-fluid levels.
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In most of the previously reported cases of intestinal perfo-
ration from C. jejuni infection, colonic dilation, particularly in
the form of toxic megacolon, was a harbinger for perforation,
although perforation in the absence of marked distension has
also been reported.7 In our case, the initial CT exhibited
moderate colonic distension, particularly in the right hemi-
colon. On further review of the initial CT, a punctate focus of
free air was seen adjacent to the liver, which was not formally
reported (Figure 4). This finding suggests a sentinel micro-
perforation that could have preceded macroscopic complica-
tions and highlights the importance of imaging review with
radiology. To our knowledge, no other study has noted this
finding.
An additional risk factor for enteric complications may be the
virulence of theC. jejuni isolate. Drug-resistantC. jejuni species
are associated with an increased risk for invasive illness and
death.9 Our patient may have grown a multidrug-resistant or-
ganism because he did not respond tomacrolide therapy within
48 hours, and his C. jejuni isolate revealed doxycycline re-
sistance on send-out testing; unfortunately, other sensitivities
were not reported. Resistance would have been unexpected,
however, because rates of macrolide resistance for C. jejuni
species from Japan are stably low.10 In patients failing to re-
spond to conventional macrolide therapy, especially those
contracting disease in regions with higher rates of drug-
resistant C. jejuni, such as Thailand, Africa, and Mexico, esca-
lation to a carbapenem or aminoglycoside should be consid-
ered.2 Our case demonstrates an atypical life-threatening
complication of colonic perforation in a common illness that
is usually self-limiting.
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